Comparative study between terazosin and alfuzosin in the treatment of patients with symptomatic benign prostatic hyperplasia.
Ishak Samir Wasfy;
Abstract
Benign prostatic hyperplasia ( BPH ) is the most common benign neoplasm in men ( Kirby and Shabbir, 2005 ), the incidence increases with increasing age. Although not a life-threatening condition, BPH can significantly affect quality of life ( Shobbir and
Other data
| Title | Comparative study between terazosin and alfuzosin in the treatment of patients with symptomatic benign prostatic hyperplasia. | Authors | Ishak Samir Wasfy | Keywords | Comparative study between terazosin and alfuzosin in the treatment of patients with symptomatic benign prostatic hyperplasia. | Issue Date | 2006 | Description | Benign prostatic hyperplasia ( BPH ) is the most common benign neoplasm in men ( Kirby and Shabbir, 2005 ), the incidence increases with increasing age. Although not a life-threatening condition, BPH can significantly affect quality of life ( Shobbir and |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.